Contextualizing what type of flexibility is needed is paramount when considering cleanroom design.
Sidney Backstrom
Advertisement
Articles by Sidney Backstrom
Why shouldn’t biopharmaceutical manufacturers be able to leverage standardized construction practices to improve time to market?
This article examines the changes now taking place, and what the future might bring.
Advertisement
Latest Updated Articles
The Quest for Cleanroom FlexibilityMay 15th 2023
Reducing Cleanroom Complexities and CostAugust 1st 2018
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Signs Point to FDA Shelving Priority Voucher Pilot, Stalling Fast-Track Drug Reviews
2
Our Biggest Takeaways From AAPS PharmSci 360
3
France Remains One of Europe’s Leading Biotech Funding Hubs
4
PharmTech AI Pulse Check: Who's Accountable When a Vendor's AI Model Changes?
5